Orion Infusion Limited (DSE:ORIONINFU)

Market Cap	8.05B
Revenue (ttm)	675.08M
Net Income (ttm)	41.22M
Shares Out	20.36M
EPS (ttm)	2.02
PE Ratio	195.38
Forward PE	n/a
Dividend	1.20 (0.30%)
Ex-Dividend Date	Dec 5, 2024

Volume	432,310
Average Volume	312,902
Open	n/a
Previous Close	406.30
Day's Range	395.10 - 410.00
52-Week Range	217.20 - 505.00
Beta	-2.46
RSI	71.90
Earnings Date	Nov 4, 2025

About Paramount Global

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Bangladesh.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1983
• Employees: 718
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONINFU

Financial Performance

In 2024, Orion Infusion's revenue was 827.42 million, an increase of 2.13% compared to the previous year's 810.15 million. Earnings were 42.33 million, an increase of 1.03%.